Results of AGM

Convatec Group PLC

21 May 2026

 

21 May 2026

Convatec Group Plc

(Convatec or the Company)

Results of the Annual General Meeting

Convatec's Annual General Meeting (AGM) was held at 20 Eastbourne Terrace, Paddington, London, W2 6LG on Thursday, 21 May 2026 at 14:00.

All resolutions set out in the Notice of Meeting were duly passed by way of a poll.  The results are set out below:

		For1		Against1		Votes total (excluding withheld2)	% of ISC voted3	Withheld2
Resolution		No of shares	%	No of shares	%
1	2025 Annual Reports and Accounts	1,583,600,321	97.97%	32,856,766	2.03%	1,616,457,087	82.69%	5,973,533
2	Remuneration Report	1,057,723,791	65.77%	550,589,931	34.23%	1,608,313,722	82.27%	14,116,898
3	Dividend	1,584,518,305	97.96%	32,961,425	2.04%	1,617,479,730	82.74%	4,950,890
4	Elect Fiona Ryder	1,578,260,187	97.58%	39,097,452	2.42%	1,617,357,639	82.74%	5,072,981
5	Re-elect Dr John McAdam	1,546,263,951	95.60%	71,094,592	4.40%	1,617,358,543	82.74%	5,072,077
6	Re-elect Jonny Mason	1,580,750,694	97.73%	36,713,081	2.27%	1,617,463,775	82.74%	4,966,845
7	Re-elect Margaret Ewing	1,568,485,590	96.98%	48,871,739	3.02%	1,617,357,329	82.74%	5,073,291
8	Re-elect Brian May	1,534,104,114	94.85%	83,252,311	5.15%	1,617,356,425	82.74%	5,074,195
9	Re-elect Professor Constantin Coussios4	WITHDRAWN
10	Re-elect Kim Lody	1,566,266,564	96.84%	51,089,725	3.16%	1,617,356,289	82.74%	5,074,331
11	Re-elect Heather Mason	1,570,362,017	97.09%	46,995,312	2.91%	1,617,357,329	82.74%	5,073,291
12	Re-elect Sharon O'Keefe	1,565,589,732	96.80%	51,764,294	3.20%	1,617,354,026	82.74%	5,076,594
13	Appoint Ernst & Young LLP as auditors	1,584,246,288	97.95%	33,122,017	2.05%	1,617,368,305	82.74%	5,062,315
14	Auditors' remuneration	1,584,397,363	97.96%	32,969,022	2.04%	1,617,366,385	82.74%	5,064,235
15	Political donations	1,526,399,577	94.09%	95,877,488	5.91%	1,622,277,065	82.99%	153,555
16	Allotment of shares	1,399,668,923	86.54%	217,704,840	13.46%	1,617,373,763	82.74%	5,056,857
17	Disapplication of pre-emption rights*	1,509,552,149	93.33%	107,800,388	6.67%	1,617,352,537	82.74%	5,078,083
18	Further disapplication of pre-emption rights*	1,403,547,455	86.78%	213,807,368	13.22%	1,617,354,823	82.74%	5,075,797
19	Purchase of own shares*	1,583,783,948	97.95%	33,142,423	2.05%	1,616,926,371	82.71%	5,504,249
20	Notice for General Meetings*	1,466,844,869	90.69%	150,521,910	9.31%	1,617,366,779	82.74%	5,063,841

Notes to the disclosure:

*Special Resolution.

1.     Votes "For" and "Against" are expressed as a percentage of votes received.

2.     A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3.     Total number of shares in issue is 1,954,852,029 (82.99% of capital was voted).

4.     As announced on 13 April 2026, Professor Constantin Coussios stepped down from his role as Non-executive Director of the Company on 30 April 2026. Accordingly, the resolution to re-elect Professor Constantin Coussios as a director of the Company (resolution 9 in the Notice of Meeting) was withdrawn.

5.     Computershare acted as scrutineer of the poll on all resolutions.

The Board is pleased that all resolutions were supported at today's AGM. We recognise the vote for Resolution 2 (Remuneration Report) was below 80%. We will continue to engage with and listen to the views of shareholders and the proxy advisers on remuneration matters, building on the engagement carried out with c. 85% of our shareholders prior to the meeting. An update on that engagement, and on any action taken as a result of these votes, will be published within six months of the AGM in accordance with the UK Corporate Governance Code, with a final summary to be included in the Company's 2026 Annual Report.

In accordance with UKLR 6.4.2, copies of the resolutions that do not constitute ordinary business that were passed at the Annual General Meeting have been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Enquiries

James Kerton

Company Secretary

Email: [e-mail]

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 3.1 Additional regulated information required to be disclosed under the laws of the United Kingdom

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com

 

END